CTI BIOPHARMA CORP (CTIC) has 119 open-market insider trades by 22 insiders since 2006. The most active filer is James A. Bianco, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark N. Lampert | Dir10% Owner | — | 2 | $123.0M | 2022-08-09 |
| BVF II GP LLC | Dir10% Owner | — | 1 | $7.6M | 2021-04-01 |
| OrbiMed Capital GP VI LLC | 10% Owner | — | 1 | $7.0M | 2021-01-07 |
| James A. Bianco | CEOPres | — | 30 | $6.8M | 2016-06-24 |
| Adam R. Craig | CEOPres | — | 8 | $4.7M | 2023-06-26 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | 10% Owner | — | 3 | $2.4M | 2016-01-08 |
| David Kirske | CFOVP | — | 5 | $1.7M | 2023-06-26 |
| Louis A. Bianco | EVPFinance & Administration | — | 12 | $1.3M | 2016-03-21 |
| BVF Partners L P/il | 10% Owner | — | 1 | $1.2M | 2016-01-08 |
| Phillip M. Nudelman Ph.D. | Dir | — | 7 | $1.2M | 2017-04-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James K. Fong | CCO & VP | Sell | $600K | 2023-01-24 |
| Adam R. Craig | CEO & President | Sell | $512K | 2023-01-24 |
| David Kirske | CFO & VP | Sell | $487K | 2022-12-29 |
| Adam R. Craig | CEO & President | Sell | $1.2M | 2022-12-29 |
| Adam R. Craig | CEO & President | Sell | $1.6M | 2022-11-09 |
| Michael A. Metzger | Director | Sell | $997K |
Companies that share insiders with CTIC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-11-08 |
| David Kirske | CFO & EVP | Sell | $13K | 2022-10-04 |
| David Kirske | CFO & VP | Sell | $1.7M | 2022-09-29 |
| David Kirske | CFO & VP | Sell | $272K | 2022-09-16 |
| Adam R. Craig | CEO & President | Sell | $1.6M | 2022-09-12 |
| Adam R. Craig | President | Buy | $28K | 2022-08-16 |
| Mark N. Lampert | Director & 10% Owner | Sell | $104.0M | 2022-08-09 |
| Michael A. Metzger | Director | Sell | $131K | 2022-07-07 |
| Michael A. Metzger | Director | Sell | $1.1M | 2022-07-05 |
| Adam R. Craig | CEO & President | Sell | $547K | 2022-07-01 |